Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Follath

Showing results (141-150 of 269) with videos related to

Pageof 27
Sort By:
Schweizerische Medizinische Wochenschrift|January 19, 2000
[Lipid-lowering therapy in patients with coronary disease: proportion of patients requiring treatment according to recommendations of the Swiss Society of Cardiology]J Muntwyler, F W Amann, F Gutzwiller, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 24, 2001
[Cost effectiveness of bisoprolol in treatment of heart failure in Germany. An analysis based on the CIBIS-II study]T D Szucs, M Schwenkglenks, B Paschen, et al.
Journal of the American College of Cardiology|November 11, 1998
Etiology and response to drug treatment in heart failureF Follath, J G Cleland, W Klein, et al.
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1985
Performance of Bayesian feedback to forecast lidocaine serum concentration: evaluation of the prediction error and the prediction intervalS Vozeh, T Uematsu, G F Hauf, et al.
European Journal of Clinical Pharmacology|January 1, 1983
The antiarrhythmic effects of controlled release disopyramide phosphate and long acting propranolol in patients with ventricular arrhythmiasP Fechter, H R Ha, F Follath, et al.
Clinical Pharmacology and Therapeutics|November 1, 1984
Influence of thyroid function on theophylline kineticsS Vozeh, M Otten, J J Staub, et al.
Zeitschrift Fur Kardiologie|February 1, 1975
[Systolic prolapse ("ballooning") of the mitral valves with secondary atrial septal defect: a still not much known combination]J Moppert, D Burckhardt, F Follath, et al.
Schweizerische Medizinische Wochenschrift|October 12, 2000
[Diagnosis and course of myocarditis: a survey in the medical clinics of Zurich University Hospital 1980 to 1998]G Sauvant, W Bossart, M O Kurrer, et al.
Clinical Chemistry|March 25, 1998
FPIA and EMIT methods compared for cyclosporine monitoring in heart transplant patientsR Fatio, G Sütsch, P Pei, et al.
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1981
Predicting individual phenytoin dosageS Vozeh, K T Muir, L B Sheiner, et al.
Pageof 27

Showing results (141-150 of 269) with videos related to

Sort By:
Pageof 27
Schweizerische Medizinische Wochenschrift|January 19, 2000
[Lipid-lowering therapy in patients with coronary disease: proportion of patients requiring treatment according to recommendations of the Swiss Society of Cardiology]J Muntwyler, F W Amann, F Gutzwiller, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 24, 2001
[Cost effectiveness of bisoprolol in treatment of heart failure in Germany. An analysis based on the CIBIS-II study]T D Szucs, M Schwenkglenks, B Paschen, et al.
Journal of the American College of Cardiology|November 11, 1998
Etiology and response to drug treatment in heart failureF Follath, J G Cleland, W Klein, et al.
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1985
Performance of Bayesian feedback to forecast lidocaine serum concentration: evaluation of the prediction error and the prediction intervalS Vozeh, T Uematsu, G F Hauf, et al.
European Journal of Clinical Pharmacology|January 1, 1983
The antiarrhythmic effects of controlled release disopyramide phosphate and long acting propranolol in patients with ventricular arrhythmiasP Fechter, H R Ha, F Follath, et al.
Clinical Pharmacology and Therapeutics|November 1, 1984
Influence of thyroid function on theophylline kineticsS Vozeh, M Otten, J J Staub, et al.
Zeitschrift Fur Kardiologie|February 1, 1975
[Systolic prolapse ("ballooning") of the mitral valves with secondary atrial septal defect: a still not much known combination]J Moppert, D Burckhardt, F Follath, et al.
Schweizerische Medizinische Wochenschrift|October 12, 2000
[Diagnosis and course of myocarditis: a survey in the medical clinics of Zurich University Hospital 1980 to 1998]G Sauvant, W Bossart, M O Kurrer, et al.
Clinical Chemistry|March 25, 1998
FPIA and EMIT methods compared for cyclosporine monitoring in heart transplant patientsR Fatio, G Sütsch, P Pei, et al.
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1981
Predicting individual phenytoin dosageS Vozeh, K T Muir, L B Sheiner, et al.
Pageof 27